- Home
- ALZN vs CREV Comparison
ALZN vs CREV Comparison
Compare ALZN & CREV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ALZN
- CREV
- Stock Information
- Founded
- ALZN 2016
- CREV 2007
- Country
- ALZN United States
- CREV Ireland
- Employees
- ALZN N/A
- CREV N/A
- Industry
- ALZN Medicinal Chemicals and Botanical Products
- CREV
- Sector
- ALZN Health Care
- CREV
- Exchange
- ALZN Nasdaq
- CREV Nasdaq
- Market Cap
- ALZN 6.1M
- CREV 7.2M
- IPO Year
- ALZN 2021
- CREV N/A
- Fundamental
- Price
- ALZN $0.69
- CREV $2.76
- Analyst Decision
- ALZN Strong Buy
- CREV Strong Buy
- Analyst Count
- ALZN 1
- CREV 1
- Target Price
- ALZN $32.00
- CREV $39.00
- AVG Volume (30 Days)
- ALZN 869.9K
- CREV 25.5K
- Earning Date
- ALZN 03-10-2025
- CREV 01-01-0001
- Dividend Yield
- ALZN N/A
- CREV N/A
- EPS Growth
- ALZN N/A
- CREV N/A
- EPS
- ALZN N/A
- CREV N/A
- Revenue
- ALZN N/A
- CREV $39,261,077.00
- Revenue This Year
- ALZN N/A
- CREV $40.76
- Revenue Next Year
- ALZN N/A
- CREV $86.18
- P/E Ratio
- ALZN N/A
- CREV N/A
- Revenue Growth
- ALZN N/A
- CREV 41.52
- 52 Week Low
- ALZN $0.66
- CREV $2.00
- 52 Week High
- ALZN $15.06
- CREV $22.34
- Technical
- Relative Strength Index (RSI)
- ALZN 24.21
- CREV 34.70
- Support Level
- ALZN $0.66
- CREV $2.72
- Resistance Level
- ALZN $0.93
- CREV $3.79
- Average True Range (ATR)
- ALZN 0.07
- CREV 0.22
- MACD
- ALZN -0.01
- CREV -0.02
- Stochastic Oscillator
- ALZN 9.00
- CREV 4.30
About ALZN Alzamend Neuro Inc.
Alzamend Neuro Inc is an early clinical-stage biopharmaceutical company. It is focused on developing novel products for the treatment of neurodegenerative diseases and psychiatric disorders, including Alzheimer's. Its mission is to develop and market safe and effective treatments. The company's pipeline consists of two novel therapeutic drug candidates, AL001 - a patented ionic cocrystal technology delivering lithium via a therapeutic combination of lithium, proline and salicylate, and AL002 - a patented method using a mutant-peptide sensitized cell as a cell-based therapeutic vaccine that seeks to restore the ability of a patient's immunological system to combat Alzheimer's.
About CREV Carbon Revolution Public Limited
Carbon Revolution PLC is an Australian-based technology company manufacturing carbon fiber wheels. It is an OEM supplier and a world-wide manufacturer of lightweight technology carbon fibre wheels to the automotive industry. The Company supplies wheels to OEMs across the globe for luxury and high-performance vehicles and SUVs, and is developing wheels for electric vehicles under contract for its OEM customers. The company generates maximum revenue Internationally.